<<

J Pharm Pharmaceut Sci (www. cspsCanada.org) 11 (3): 66-67, 2008

Pathology and Therapeutics for : A Basis for Clinical Practice, 3rd Edition Greene RJ and Harris ND (Eds). Pharmaceutical Press, London (UK), 2008. ISBN 978 0 85369 690 2.

Finding just the right textbook is a Cautions and interactions are also not challenge that many pharmacists and pharmacy comprehensive. The authors emphasize the need to students are faced with. Oftentimes we are left with look up additional reference sources to confirm little choice than to have several resources at our dosing and full product monograph information. fingertips. Considering the volume of knowledge Titles such as “Some important ”, or that is demanded of pharmacists, a that “Some antimuscarinics” indicate that the topics are provides efficient access to critical information is selected, rather than comprehensive. essential. The and Therapeutics for Pharmacists: A basis for practice, This text is divided into two parts. In first is such a book. part, with its two chapters, the authors give a very brief outline surrounding the of therapeutic The text is an ideal reference for strategy in the first chapter while in the second pharmacists and pharmacy students. As the authors chapter they discuss the principles of pathology. . note in the preface to their first edition, “Our aim is The first section, titled “Basic strategy and to show the rationale and role of in the introduction to pathology”, provide a basis for the management of some common through a rest of the text. The first chapter includes a review consideration of the mechanisms of of terminology, how to read/provide a case history, processes in relation to normal .” They drug disposition, and principles of drug selection. note that the text is now designed to enhance patient The second chapter focuses on maladaptation as the care and management by pharmacists who now process of disease. The authors break down have expanded scopes of practice. pathology into four classifications, including , degeneration, neoplastic changes, This is the third edition, and some and inherited disease. The remainder of the chapter significant updates have been made from the then focuses on (20 pages), previous edition. The authors have included more inflammation (10 pages), and (5 pages). evidence-based content and highlighted areas where Although excellent reviews, the four classifications guidelines should be applied. The structure has also of disease are not always referred to, possibly improved, with each chapter in a consistent format, leading to disconnect between understanding the and the overall text is much easier to read, with basic disease processes and the classifications of better designed headings. There is a new chapter on pathological processes used by the authors. haematolgoic disease and significantly expanded content in other chapters, such as a section on The vast majority of the textbook is left to in renal impairment found in the renal chapter. the second part, which contains 12 chapters. The chapter headings are arranged in the same order as The book is written by authors in the UK, the British National Formulary (BNF) (including GI and certainly has a focus on , cases, and liver diseases, cardiovascular system, and guidelines relevant to that setting. However, respiratory diseases, central nervous system, pain when international guidelines are available they are and its treatments, infections and antimicrobial referred to in the text. There are some gaps in the therapy, endocrine system, neoplastic disease, text, which the authors note in the preface. For haematology, , skin disease, and the example, they highlight the most serious or most renal system). These headings will be in contrast to common adverse drug events, rather than providing some textbooks, that include additional chapters, a comprehensive list of all reported adverse effects. such as men’s and women’s issues,

66 J Pharm Pharmaceut Sci (www. cspsCanada.org) 11 (3): 66-67, 2008

ophthalmic conditions, etc. Each chapter starts off physical findings, and details about non- with a generous review of that is aimed pharmacologic , such as use of oxygen to give an awareness of how the symptoms develop. masks. This introduction serves as a into the overview of the disease and its hallmarks. The authors move Readers looking for information riddled through , pathology and and with citations and statistical graphs or tables finally to clinical features of the disease state of extracted from various clinical trials will be interest. Now the reader is intended to be confident somewhat disappointed. Indeed, the authors have with tackling principles of management. These acknowledged the rising dominance of evidence sections cover various therapeutic topics within the based , nodding to major or ground- chapter. For example, anxiety would be a specific breaking studies but only when they deem it topic within the CNS chapter and within that are absolutely relevant. It is clear that the authors summaries such as aims and strategy, non-drug purposely chose not to break from their clear and therapy, descriptions of each drug while engaging narrative style that places a tremendous finishing with recommendations on drug selection emphasis on ample understanding of a disease based on the clinical scenario. while constantly begging the question, “Why?”

In some chapters the authors present the This resource provides a refreshing guide to from a broader perspective, versus just the essentials of clinical practice. If one is looking reviewing each drug’s monograph. Each drug class for tables with specific half-lives, dosage ranges is described under a general heading, such as etc, then other resources may be more applicable. “action”, or “biopharmacy and ” This text has the advantage of not leaving the reader before moving on to the next heading, where each overwhelmed. Rather, it is be an ideal text for drug class is revisited. Such a manner of presenting students or pharmacists who have a for information is useful for comparing medications academic support that can fill the knowledge and and classes. This is valuable when practice gaps. trying to differentiate drugs from one another. Ernest Law Almost every page has some sort of Third Year BSc Pharm Student graphic, which complements the text and provides Faculty of Pharmacy & Pharmaceutical Sciences an easy to read reference for information. They University of Alberta also include tables on topics that normally would be Edmonton, AB glossed over in a sentence of two in other textbooks. For example, there is an entire table Cheryl A. Sadowski, devoted to “Problems with digoxin therapy”. The B.Sc.(Pharm), Pharm.D. Associate Professor disease based graphics include step-wise Faculty of Pharmacy & Pharmaceutical Sciences approaches to disease. There is a number of University of Alberta photographs included in the skin disorders Edmonton, Alberta chapter.There are also “extras” that most pharmacy [email protected] textbooks do not contain, such as cartoons of

67